Glyoxal cross-linked
porous magnetic chitosan microspheres, GMS
(∼170 μm size), with a tunable degradation profile were
synthesized by a water-in-oil emulsion technique to accomplish controlled
delivery of doxorubicin (DOX), a chemotherapeutic drug, to ensure
prolonged chemotherapeutic effects. The GMS exhibit superparamagnetism
with saturation magnetization,
M
s
= 7.2
emu g
–1
. The
in vitro
swelling
and degradation results demonstrate that a swelling plateau of GMS
is reached at 24 h, while degradation can be modulated to begin at
96–120 h by formulating the cross-linked network using glyoxal.
MTT assay, live/dead staining, and F-actin staining (actin/DAPI)
validated the cytocompatibility of GMS, which further assured good
drug loading capacity (35.8%). The release mechanism has two stages,
initiated by diffusion-inspired release of DOX through the swollen
polymer network (72 h), which is followed by a disintegration-tuned
release profile (>96 h) conferring GMS a potential candidate for
DOX
delivery.